Innovating methods for planning, producing, and using real-world evidence
Real-world data (RWD) are a critical element of the evidence needed to help reach this goal, potentially informing a new drug’s development or providing insight for its use after it comes onto market. But current frameworks for analyzing RWD aren’t sufficient to provide the detailed, patient-level information that’s really needed for treatment decisions.
Get the research brief series
Innovating methods for planning, producing, and using real-world evidenceJul 20, 2023
ISPOR 2023 Workshop Recap: “From Concept to Practice: How to Tactically Design a Feasible Outcomes-Based Contract in Oncology”May 24, 2023
Symposium recap: Uncertainty Management in Drug Evaluations: From Evidence to Reimbursement & Clinical UseMay 23, 2023
How an RWE Value-Based Infrastructure Could Enable Payment InnovationMay 23, 2023
NEWDIGS Consortium Awarded Danaher Foundation Community Impact GrantMar 28, 2023
Cross-stakeholder collaboration for system-wide innovation
The NEWDIGS Consortium focuses on improving patients’ healthcare outcomes by accelerating appropriate and timely access to biomedical products in ways that are sustainable by all stakeholders.
Bringing system innovation to your organization
NEWDIGS IMPACT offers flexible and custom-designed programs to engage your organization’s strategists and decision makers in system innovations that your organization can adopt.
Targeted and customizable programs
Our educational programs help organizations address complex healthcare innovation problems, enhance understanding of strategic topic areas, build organizational capacity for cross-functional design, pressure test solutions with an integrated systems view, and more.